Mandate

VINGE ADVISES GRÄNGES IN CONNECTION WITH THE LISTING ON NASDAQ STOCKHOLM

October 10, 2014

Vinge advises Gränges AB (publ) in connection with the company’s listing on Nasdaq Stockholm.

Gränges is a leading global supplier of rolled products for the brazed aluminum heat exchanger industry. The Company develops, produces and markets advanced materials that enhance both production economy during the customer manufacturing process, as well as the performance of the final products, the brazed heat exchangers. Gränges’ vision is to help create smaller, lighter and more designable heat exchangers, to increase economic efficiency and reduce environmental impact. The Swedish language prospectus was published on 29 September 2014 and the first day of trading was 10 October 2014. The offering price has been set at SEK 42.50 per share, corresponding to a market value of Gränges of approximately SEK 3,200 million.

Vinge’s team primarily consisted of Carl Gustaf de Geer, Jesper Schönbeck, Charlotte Levin, Katarina Nilsson, Kristian Ford, Rikard Lindahl, Filip Brosset and Henrik Jonsson.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026